| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |